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Background. We investigated the pathogenesis of pneumo-
coccal pneumonia using clinical specimens collected for pneu-
monia surveillance in The Gambia. 
Methods. Lung aspirates and nasopharyngeal swabs from 
31 patients were examined by culture, quantitative polymerase 
chain reaction (qPCR), whole genome sequencing, serotyping, 
and reverse-transcription qPCR.
Results. Five lung aspirates cultured pneumococci, with a 
matching strain identified in the nasopharynx. Three virulence 
genes including ply (pneumolysin) were upregulated >20-fold 
in the lung compared with the nasopharynx. Nasopharyngeal 
pneumococcal density was higher in pediatric pneumonia pa-
tients compared with controls (P < .0001). 
Conclusions. Findings suggest that changes in pneumo-
coccal gene expression occurring in the lung environment may 
be important in pathogenesis.
Keywords.  lung; nasopharynx; pneumococcus; pneu-
monia; Streptococcus pneumoniae.
Streptococcus pneumoniae (the pneumococcus) is a common 
cause of community-acquired pneumonia, a major public 
health problem that primarily affects young children and the 
elderly. Pneumococcal pneumonia is believed to occur when 
pneumococci colonizing the upper respiratory tract are aspi-
rated into the lung, where a failure to clear the bacteria leads 
to replication and triggers a damaging immune response. 
Supporting clinical data are limited because lung aspirates are 
not routinely collected in most settings; however, a previous 
study from The Gambia found that 85% of pediatric pneumonia 
patients with pneumococci identified in lung aspirates had the 
same serotype detected in a nasopharyngeal swab [1]. Studies 
have found higher pneumococcal loads in the nasopharynx 
in children with pneumonia compared with healthy controls, 
suggesting that increased pneumococcal density in the naso-
pharynx may facilitate bacterial spread to the lung, or alterna-
tively, may be due to pneumonia [2, 3]. The processes by which 
pneumococci transition from a colonizing to a pathogenic state 
are not well understood.
Pneumococci possess a variety of virulence factors, including 
polysaccharide capsule, the toxin pneumolysin, adhesins, and 
surface proteins that allow them to cause disease [4]. After 
examining pneumococcal gene expression in a range of in 
vitro conditions designed to mimic host microenvironments, 
Aprianto et al [5] identified 498 conditionally expressed genes, 
highlighting the dynamic transcriptional ability of the pneumo-
coccus. Experiments using animal models demonstrated that 
the pneumococcus modifies its gene expression in response 
to different niches within the host [6, 7]. To date, only a single 
published study has examined pneumococcal gene expression 
in clinical samples. Using nasopharyngeal swabs collected from 
healthy children, Sakai et al [8] found different levels of expres-
sion for 11 pneumococcal genes, demonstrating the feasibility 
of evaluating pneumococcal gene expression directly from clin-
ical samples.
Using a unique set of samples collected as part of pneumonia 
surveillance in The Gambia, we sought to investigate the path-
ogenesis of pneumococcal pneumonia by comparing pneu-
mococcal loads in the nasopharynx of pneumonia patients 
and healthy carriers, conducting whole genome sequencing of 
paired pneumococcal isolates obtained from the nasopharynx 
and lung of pneumonia patients, and analyzing pneumococcal 
gene expression directly from nasopharyngeal swabs and lung 
aspirates.
METHODS
Detailed methods are provided in the Supplementary 
Information. This study was nested within population-based 
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surveillance for suspected pneumonia, septicemia, and men-
ingitis among patients aged 2  months or greater in the Basse 
Health and Demographic surveillance system in The Gambia, 
as described previously [9]. All patients with suspected pneu-
monia who had a lung aspiration from April 2015 to May 2016 
were included in this study. Nasopharyngeal swabs were col-
lected from pneumonia patients and community controls. 
For all swabs and lung aspirates, an aliquot for ribonucleic 
acid (RNA) analysis was prepared by adding 2-fold volume of 
RNAprotect Bacteria Reagent (QIAGEN) to the clinical sample.
The surveillance project and this substudy were approved 
by The Gambia Government/Medical Research Council Joint 
Ethics Committee (approval numbers 1087 and L2016.09v2). 
Patients or their parent or guardian provided written informed 
consent for enrolment in the surveillance project and lung 
aspiration.
Laboratory Procedures
In brief, nasopharyngeal swab samples underwent deoxyri-
bonucleic acid (DNA) extraction and lytA real-time quantita-
tive polymerase chain reaction (qPCR) to detect and quantify 
pneumococci. Pneumococcal density data are reported as ge-
nome equivalents/mL (GE/mL). Molecular serotyping by micro-
array was conducted on nasopharyngeal swabs. Pneumococci 
isolated from the lung and nasopharynx were serotyped 
by traditional antibody-based methods and whole genome 
sequencing conducted using the MiSeq platform. Expression of 
9 pneumococcal genes selected from the literature was exam-
ined by reverse-transcription qPCR after RNA extraction from 
clinical specimens. Genes and primer sequences are provided in 
Supplementary Table 1.
Data analysis was performed using STATA version 15.1 and 
GraphPad Prism version 7.03. Categorical data were compared 
using the χ 2 test. Pneumococcal density data were log10 trans-
formed before analysis and examined using non-parametric 
methods. Densities were compared using the Mann-Whitney 
test, and multivariable quantile regression models included age, 
sex, and Pneumococcal conjugate vaccine (PCV) status as vari-
ables selected a priori.
RESULTS
Samples from 31 pneumonia patients enrolled in surveil-
lance were included in this study. Patient ages ranged from 
2 months to 73 years, with a median of 3.8 years (interquar-
tile range [IQR], 1.7–7.0). The majority were children, with 
20 (65%) aged <5  years, 6 (19%) from 5 to 18  years, and 5 
(16%) >18 years, and 20 of 31 (65%) were male. Examination 
of nasopharyngeal swabs from patients of all ages found that 
27 (87%) contained pneumococci. We compared the preva-
lence, density, and serotypes of pneumococci in the naso-
pharynx of patients <5 years of age with community controls. 
Participant characteristics are shown in Supplementary Table 
2. Pneumococcal prevalence was similar in pneumonia pa-
tients (18 of 20; 90%) and community controls (21 of 22, 96%, 
P = .493, χ 2 test). Among children with pneumococci detected 
in the nasopharynx, median density was higher in pneumonia 
patients (7.77 log10 GE/mL; IQR, 7.33–7.98) compared with 
controls (6.05; IQR, 5.67–6.47; P < .0001). When adjusted 
for age, sex, and PCV status, the difference remained signif-
icant, with a coefficient (difference between medians) of 1.61 
log10 GE/mL (95% confidence interval, 0.96–2.26; P < .001). 
Serotypes identified in nasopharyngeal swabs from pneu-
monia patients and controls are shown in Figure  1. Eight 
serotypes were found in both participant groups, with 8 ad-
ditional serotypes found only in pneumonia patients and 11 
only found in community controls.
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Figure 1. Mirror plot of pneumococcal serotypes identified in nasopharyngeal swabs of children <5 years of age hospitalized with pneumonia (orange bars) compared 
with pneumococcal serotypes found in nasopharyngeal swabs collected from community controls (blue bars). NT3b refers to a lineage of nonencapsulated Streptococcus 
pneumoniae.
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Culture of lung aspirates from 31 pneumonia patients 
of all ages identified pneumococci as the causative or-
ganism in 5 patients (serotypes 3, 14, 1, 12F, and 32A; 
n = 1 each) and Staphylococcus aureus in 1. All 5 patients 
who had pneumococci cultured from the lung aspirate had 
the same serotype identified in their nasopharyngeal swab. 
Pneumococcal lytA qPCR was conducted for the lung as-
pirates with sufficient volume remaining for analysis 
(n = 25). Ten (40%) lung aspirates tested positive by qPCR, 
including the 5 samples that were also positive by culture. 
Median pneumococcal density was higher in the culture-
positive lung aspirates (5.74 log10 GE/mL; IQR, 4.93–5.93) 
compared with the culture-negative lung aspirates (3.32 
log10 GE/mL; IQR, 2.86–3.88; P = .008).
To identify within-host genomic changes, in particular DNA mu-
tations that may contribute to pneumococcal pathogenesis, whole 
genome sequencing was conducted on the 5 paired pneumococcal 
isolates from the lung and nasopharynx of the same patient. For all 5 
patients, the isolate from the nasopharynx was the same as that from 
the lung, with >99% sequence similarity and matching multilocus 
sequence types (Supplementary Table 3). Three mutations were iden-
tified in isolates from lung aspirates (Supplementary Table 4).
We investigated differences in pneumococcal gene expres-
sion by examining RNA extracted directly from nasopharyngeal 
swabs and lung aspirates from the same 5 patients. After evalua-
tion of RNA concentration and quality, samples containing sero-
type 3 were excluded from analysis due to DNA contamination, 
and samples containing serotype 14 were excluded due to insuffi-
cient RNA yield from the lung aspirate. Differences in expression 
of 9 genes in the lung aspirate compared with the nasopharynx 
are shown in Figure 2. Virulence genes ply (pneumolysin), nanA 
(neuraminidase A), and the putative virulence regulator yeeN were 
consistently and strongly upregulated (fold change >20) in the lung 
compared with the nasopharynx. In contrast, psaB (pneumococcal 
surface antigen B), endA (endonuclease), and the quorum sensing 
gene luxS were upregulated to a lesser extent, or varied by strain. 
Genes encoding pyruvate oxidase and enolase (spxB, and eno, re-
spectively) were downregulated in the lung, most prominently in 
serotype 1. Expression of lytA (autolysin) was downregulated in 
12F but upregulated in serotypes 1 and 32A.
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Figure 2. Differential expression of pneumococcal genes in lung aspirates compared with nasopharyngeal swabs collected from the same patient by reverse-transcription 
quantitative polymerase chain reaction. Fold change in gene expression was derived using the 2−ΔΔCt method with gyrA as the reference gene. Each bar represents data from 
one gene in 1 set of patient samples. * indicates an imputed Cycle threshold (Ct) value of 40 used for the lung aspirate sample. For serotype 12F, data for nanA are not avail-
able because no transcripts were detected in either sample.
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DISCUSSION
We investigated the microbiological features of pneumococcal 
pneumonia using a unique set of clinical specimens obtained 
as part of pneumonia surveillance in The Gambia. This is a 
high pneumococcal carriage setting, reflected in the high col-
onization rates observed in both pneumonia patients and 
community controls. In children under 5  years of age, pneu-
mococcal densities in the nasopharynx were over 1 log higher 
in pneumonia patients compared with controls. These results 
are consistent with data from Vietnam and the multicenter 
Pneumonia Etiology Research for Child Health (PERCH) study 
[2, 3]. Using whole genome sequencing, we demonstrated that 
pneumococci present in the lung of pneumonia patients origin-
ated from the nasopharynx. Although our study numbers were 
small, a previous study in The Gambia found the same serotype 
in the nasopharynx and lung for 23 of 27 (85%) pneumonia 
cases [1]. A multicenter study of children <5 years hospitalized 
for pneumonia reported that for 34 cases with pneumococci de-
tected in blood, 27 (79%) had the same serotype detected in the 
nasopharynx [10]. These findings, taken together, provide fur-
ther evidence that pneumococcal pneumonia originates from 
bacteria present in the upper respiratory tract, and they suggest 
that sampling the nasopharynx may provide some insight into 
pneumonia etiology.
A major finding from our study is that few DNA mutations 
were acquired by the pneumococcus during disease, whereas 
prominent differences in pneumococcal gene expression were 
observed between the lung and the nasopharynx. Although it 
is possible that mutations, for example in the psaB promoter 
region, may have impacted virulence, our results suggest that 
transcriptional differences rather than genomic changes un-
derpin pneumococcal pathogenesis within the host. The ply 
gene, which encodes the pore-forming toxin pneumolysin, was 
strongly upregulated in the lung for all 3 isolates examined. 
Expression of endA, which encodes an endonuclease that de-
grades neutrophil extracellular traps (NETs), was upregulated 
in the lung, whereas eno, which encodes an enolase that can 
induce NET formulation, was downregulated [11, 12]. These 
results suggest that avoidance of NETs may facilitate pneumo-
coccal survival in the lung. SpxB has been linked to multiple 
pneumococcal activities, including virulence, colonization, 
capsule synthesis, and transmission. Downregulation of spxB in 
the lung may relate to one of these functions or its metabolic 
role in oxygen sensing and carbon source utilization [13]. It is 
interesting to note that the serotype 1 isolate displayed the most 
prominent changes in gene expression in the lung. This isolate 
belongs to sequence type 3081, a clone that is the leading cause 
of invasive pneumococcal disease in The Gambia and is highly 
virulent in animal models [14].
Viral testing was not conducted as part of this study. Not all 
lung aspirates underwent lytA qPCR, and serotyping was not 
conducted on the 5 culture-negative, lytA-positive lung aspir-
ates. One key limitation is that gene expression studies were 
restricted to 3 paired specimens. We did not evaluate the ex-
pression of capsule, an important virulence factor. Certain cap-
sular serotypes have been linked to pneumonia: serotypes 1, 5, 
22F, 7F, and 14 were more likely to be found in the nasopharynx 
of children with pneumonia than in healthy controls in a study 
conducted before PCV use [15]. A similar study conducted in 
a post-PCV population would provide useful data for consider-
ation of serotype coverage of next-generation PCVs. Although 
our sample size was small, data suggested a differing serotype 
distribution between pneumonia patients and community car-
riers, with serotypes 1 and 5 identified solely in patients.
CONCLUSIONS
There is a paucity of data on pneumococcal gene expression 
from clinical samples, with 1 study to date examining pneu-
mococcal RNA in the nasopharynx of healthy carriers [8]. Due 
to technical challenges, only 3 paired samples from our study 
were suitable for analysis of pneumococcal gene expression. 
Nevertheless, this study represents a proof-of-concept for con-
ducting pneumococcal gene expression analysis directly from 
patient clinical specimens, identifying considerable changes in 
expression that occur within the lung. Although we hypothesize 
that the lung environment triggered these changes, other fac-
tors may have facilitated pneumococcal spread to the lung, and 
evaluating additional isolates is warranted. More important, 
specimens were stored in an RNA-stabilizing reagent promptly 
after collection. Future studies may expand upon the current 
findings by examining other sample types, such as sputum 
or pleural fluid, or applying transcriptomic approaches such 
as RNA sequencing (RNA-seq) to examine global changes in 
pneumococcal gene expression. In an experimental model, dual 
RNA-seq has been used to identify transcriptional changes in 
both pneumococci and the host associated with pneumococcal 
invasion into the pleural space [6]. The identification of mo-
lecular signatures associated with pneumococcal pneumonia 
could inform development of novel diagnostics and protein-
based vaccines. We envision that future studies building upon 
this approach will extend our understanding of the pathogen-
esis of pneumococcal pneumonia.
Supplementary Data
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Notes
Disclaimer. Funders had no role in study design, analysis, 
and interpretation of data, or manuscript preparation.
D
ow
nloaded from
 https://academ
ic.oup.com
/jid/advance-article-abstract/doi/10.1093/infdis/jiaa186/5823762 by guest on 01 June 2020
 BRIEF REPORT • jid 2020:XX (XX XXXX) • 5
Financial support. Pneumonia surveillance in The Gambia 
was funded by Gavi, the Vaccine Alliance, the Bill & Melinda 
Gates Foundation (OPP1020327), and the UK Medical Research 
Council. This study was funded by the Murdoch Children’s 
Research Institute, which was supported by the Victorian 
Government’s Operational Infrastructure Support Program. 
C. S. was supported by an Australian National Health Medical 
Research Council Career Development Fellowship (1087957) 
and a Veski Inspiring Women Fellowship. Y. H. was supported 
by a student research award from the Australian Society for 
Microbiology Victorian Branch. 
Potential conflicts of interest. C. S., E. M. D., and E. K. 
M. are investigators on an unrelated study funded by Pfizer. 
J. H. is an investigator on studies undertaken on behalf of St 
George’s, University of London or BUGS Bioscience that are 
sponsored or funded by vaccine manufacturers, including 
Pfizer, GlaxoSmithKline and Sanofi Pasteur. All authors 
have submitted the ICMJE Form for Disclosure of Potential 
Conflicts of Interest. Conflicts that the editors consider rel-
evant to the content of the manuscript have been disclosed. 
References
1. Tokarz  R, Briese  T, Morris  G, et  al. Serotype analysis of 
Streptococcus pneumoniae in lung and nasopharyngeal as-
pirates from children in the Gambia by MassTag PCR. J 
Clin Microbiol 2013; 51:995–7.
2. Vu  HT, Yoshida  LM, Suzuki  M, et  al. Association 
between nasopharyngeal load of Streptococcus 
pneumoniae, viral coinfection, and radiologically con-
firmed pneumonia in Vietnamese children. Pediatr 
Infect Dis J 2011; 30:11–8.
3. Baggett HC, Watson NL, Deloria Knoll M, et al.; PERCH 
Study Group. Density of upper respiratory colonization 
with Streptococcus pneumoniae and its role in the diagnosis 
of pneumococcal pneumonia among children aged <5 years 
in the PERCH Study. Clin Infect Dis 2017; 64:317–27.
4. Weiser  JN, Ferreira  DM, Paton  JC. Streptococcus 
pneumoniae: transmission, colonization and invasion. Nat 
Rev Microbiol 2018; 16:355–67.
5. Aprianto  R, Slager  J, Holsappel  S, Veening  JW. High-
resolution analysis of the pneumococcal transcriptome 
under a wide range of infection-relevant conditions. Nucleic 
Acids Res 2018; 46:9990–10006.
6. Ritchie  ND, Evans  TJ. Dual RNA-seq in Streptococcus 
pneumoniae infection reveals compartmentalized neutro-
phil responses in lung and pleural space. mSystems 2019; 
4:e00216–19.
7. Ogunniyi AD, Mahdi LK, Trappetti C, et al. Identification 
of genes that contribute to the pathogenesis of invasive 
pneumococcal disease by in vivo transcriptomic analysis. 
Infect Immun 2012; 80:3268–78.
8. Sakai  F, Talekar  SJ, Klugman  KP, Vidal  JE. Expression of 
Streptococcus pneumoniae virulence-related genes in the 
nasopharynx of healthy children. PLoS One 2013; 8:e67147.
9. Mackenzie GA, Plumb ID, Sambou S, et al. Monitoring the 
introduction of pneumococcal conjugate vaccines into West 
Africa: design and implementation of a population-based 
surveillance system. PLoS Med 2012; 9:e1001161.
10. Dananché  C, Paranhos-Baccalà  G, Messaoudi  M, et al. 
Serotypes of Streptococcus pneumoniae in children aged 
<5 years hospitalized with or without pneumonia in devel-
oping and emerging countries: a descriptive, multicenter 
study. Clin Infect Dis 2020; 70:875–83. 
11. Zhu  L, Kuang  Z, Wilson  BA, Lau  GW. Competence-
Independent Activity of Pneumococcal Enda Mediates 
Degradation of Extracellular DNA and Nets and Is 
Important for Virulence. PLoS One 2013; 8:e70363.
12. Mori  Y, Yamaguchi  M, Terao  Y, Hamada  S, Ooshima  T, 
Kawabata S. α-Enolase of Streptococcus pneumoniae induces 
formation of neutrophil extracellular traps. J Biol Chem 
2012; 287:10472–81.
13. Carvalho  SM, Farshchi  Andisi  V, Gradstedt  H, et  al. 
Pyruvate oxidase influences the sugar utilization pattern 
and capsule production in Streptococcus pneumoniae. PLoS 
One 2013; 8:e68277.
14. Bricio-Moreno L, Ebruke C, Chaguza C, et al. Comparative 
genomic analysis and in vivo modeling of Streptococcus 
pneumoniae ST3081 and ST618 isolates reveal key ge-
netic and phenotypic differences contributing to clonal re-
placement of serotype 1 in The Gambia. J Infect Dis 2017; 
216:1318–27.
15. Greenberg D, Givon-Lavi N, Newman N, Bar-Ziv J, Dagan R. 
Nasopharyngeal carriage of individual Streptococcus 
pneumoniae serotypes during pediatric pneumonia as a 
means to estimate serotype disease potential. Pediatr Infect 
Dis J 2011; 30:227–33.
D
ow
nloaded from
 https://academ
ic.oup.com
/jid/advance-article-abstract/doi/10.1093/infdis/jiaa186/5823762 by guest on 01 June 2020
